Business Context and Reporting Period
This Form 8-K is filed by Conversion Labs, Inc. (not Lifemd, Inc.) on November 17, 2020. The report details the consummation of a private placement offering and the conversion of outstanding convertible promissory notes.
Key Financial Metrics
- Private Placement Proceeds: The company sold 3,044,529 shares of common stock for an aggregate purchase price of $14,461,513, resulting in net proceeds of approximately $13.2 million.
- Note Conversion: Convertible promissory notes issued in May 2020 with an aggregate principal of $1,000,000 were converted into common stock at a price of $2.50 per share.
- Pro Forma Equity: As of September 30, 2020, stockholders' equity improved from a deficit of approximately $8.0 million to a positive equity of approximately $6.3 million on a pro forma basis.
- Revenue and Profit: The filing text does not provide specific revenue, profit, or cash flow figures for the reporting period.
Material Changes
The primary material change is the significant improvement in the company's capital structure. The combination of the private placement and the note conversions eliminated a prior equity deficit of $8.0 million, resulting in a pro forma positive equity position of $6.3 million as of September 30, 2020.
Outlook, Risks, and Contingencies
The filing includes unaudited condensed consolidated pro forma financial information (Exhibit 99.1) which assumes the offering occurred as of September 30, 2020. Management notes that this pro forma data does not necessarily reflect actual future financial positions or results of operations. The information is subject to risks and uncertainties discussed in the company's Form 10-K and Form 10-Q under the "Risk Factors" section.
Investor Verification Checklist
- Verify the discrepancy between the requested company name (Lifemd, Inc.) and the actual registrant (Conversion Labs, Inc.).
- Review the attached Exhibit 99.1 for the detailed unaudited pro forma balance sheet.
- Consult the Form 10-K (filed March 30, 2020) and Form 10-Q (filed November 16, 2020) for historical financial performance and risk factors.
- Confirm the final share count post-conversion of the May 2020 Notes.